SCHEMBL14006342

SCHEMBL14006342

C/C=N/OCc1ccc(Cl)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.53
SMN1; SMN2 Q16637 2/20 0.49
IDO1 P14902 2/20 0.47
AGXT P21549 2/20 0.47
KMT2A Q03164 7/20 0.47
MEN1 O00255 6/20 0.47
MAPT P10636 4/20 0.47
TDP1 Q9NUW8 1/20 0.47
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 4/20 0.41
GLA P06280 1/20 0.41
LMNA P02545 1/20 0.40
MAOB P27338 3/20 0.39
APP P05067 1/20 0.39
POLB P06746 3/20 0.39
HTT P42858 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
NPC1 O15118 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10617880 1.00 L3MBTL1 (0.53) L3MBTL1SMN1; SMN2IDO1AGXTKMT2A
SCHEMBL15865984 0.82 AGXT (0.48) L3MBTL1SMN1; SMN2IDO1AGXTMAPT
SCHEMBL17219302 0.81 SMN1; SMN2 (0.54) L3MBTL1SMN1; SMN2IDO1AGXTKMT2A
SCHEMBL20732770 0.81 SMN1; SMN2 (0.54) L3MBTL1SMN1; SMN2IDO1AGXTKMT2A
SCHEMBL17218954 0.81 L3MBTL1 (0.50) L3MBTL1SMN1; SMN2IDO1AGXTKMT2A
SCHEMBL6684569 0.80 IDO1 (0.47) L3MBTL1SMN1; SMN2IDO1AGXTKMT2A
SCHEMBL17215939 0.79 L3MBTL1 (0.49) L3MBTL1SMN1; SMN2IDO1AGXTKMT2A
SCHEMBL20732769 0.79 L3MBTL1 (0.49) L3MBTL1SMN1; SMN2IDO1AGXTKMT2A
SCHEMBL134049 0.79 NPC1 (0.46) L3MBTL1SMN1; SMN2IDO1AGXTKMT2A
SCHEMBL211957 0.79 NPC1 (0.46) L3MBTL1SMN1; SMN2IDO1AGXTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414238-B1 SUBSTITUTED IMIDAZOLYL-CARBOXAMIDES AS PESTICIDES BAYER CROPSCIENCE AG (DE) 2021-03-24 EP disclosed
WO-2017137319-A1 SUBSTITUTED -OXYIMIDAZOLYL-CARBOXAMIDES AS PEST CONTROL AGENTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-08-17 WO disclosed
US-20080293674-A1 Azinyl Imidazoazine and Azinyl Carboxamide BAYER CROPSCIENCE AG (DE) 2008-11-27 US disclosed
US-20080293674-A1 Azinyl Imidazoazine and Azinyl Carboxamide BAYER CROPSCIENCE AG (DE) 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293674-A1 Azinyl Imidazoazine and Azinyl Carboxamide AZI2, NISCH, ZYX L3MBTL1 3539/4885SMN1; SMN2 4090/4885IDO1 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.